Eli Lilly played down risks of top drug: report
245346
Drug giant Eli Lilly has engaged in a decade-long effort to play down the health risks of its top-selling medication, the schizophrenia drug Zyprexa, The New York Times reported in Sunday editions.
79075
Eli Lilly pushed Zyprexa, a drug for schizophrenia and bipolar disorder, as a treatment for older patients with dementia, according to marketing materials.
427427
Eli Lilly and Co.  said on  Wednesday its fourth-quarter earnings fell, hurt by a number of  special charges.
339894
Drugmaker Eli Lilly and Co. LLY.N on  Thursday said it will eliminate up to 575 U.S. positions,  representing 2 percent of its U.S. work force, in order to  streamline operations and reduce costs.
299049
Eli Lilly and Co.  on Tuesday  posted better-than-expected second-quarter earnings helped by  surging sales of its prescription drugs, including depression  treatment Cymbalta, and the company raised its 2007 profit  forecast.
216500
Eli Lilly and Co. on Thursday said one of its experimental drugs was comparably effective in a mid-stage trial as the company's widely used Zyprexa treatment, but without weight gains seen with Zyprexa.
346082
Eli Lilly and Co  on Tuesday said fourth-quarter profit rose on lower taxes and better-than-expected sales of its medicines, including its newer treatments for depression, diabetes and cancer.
567241
Drug company Eli Lilly  has  encouraged primary care physicians to use Zyprexa, a powerful  drug for schizophrenia and bipolar disorder, in patients who  did not have either condition, the New York Times reported on  its Web site on Monday, citing internal Lilly marketing  materials.
526091
Drugmaker Eli Lilly and Co. LLY.N on  Wednesday said its restructuring will result in a  fourth-quarter charge of 24 cents to 27 cents per share, above  its previous estimate of 19 to 24 cents per share.
154967
Eli Lilly and Co. LLY.N on Wednesday  reported a fourth-quarter net loss on charges for restructuring  and taxes related to the return of overseas profits, as sales  of prescription drugs rose only slightly.
4655
Drugmaker Eli Lilly and Co.  on Wednesday said it will make clinical trial information available online amid calls by lawmakers and physicians for more disclosure of negative trial results.
114399
Pfizer Inc., the world&#39;s biggest drugmaker, defended its painkiller Celebrex after a researcher&#39;s suggestion the medication may be linked to heart risks sent the stock down as much as 8.3 percent.
428974
Stocks fell on Friday, led by pharmaceutical shares after a US health official raised concerns about drug safety and a drop in chip-equipment makers following a ratings downgrade by Goldman Sachs.
41158
Eli Lilly and Co.  said on Wednesday its fourth-quarter earnings fell sharply, hurt by a $495 million charge to cover a settlement with former users of its Zyprexa schizophrenia drug.
481646
Eli Lilly and Co. said on Tuesday that  U.S. regulators have approved its new antidepressant as a  treatment for pain associated with nerve damage in diabetics,  making it the first drug approved for the disorder and sending  the company's shares up 2 percent.
92784
Pfizer, AstraZeneca and Eli Lilly - each disclosed serious problems with important medicines yesterday, throwing a spotlight on the fact that the $500 billion
421903
In a surprising setback for the world's largest drugmaker, Pfizer Inc.  halted development on Saturday of its top experimental medicine, the cholesterol drug torcetrapib, due to safety concerns.